Honouring a legacy: Malcolm Legget MNZM
Associate Professor Dr Malcolm Legget was awarded the MNZM for services to neuroendocrine cancer care in New Zealand.

Associate Professor Dr Malcolm Legget has been awarded the MNZM in recognition of his services to neuroendocrine cancer care in Aotearoa New Zealand.
His achievements for our community include spearheading efforts to bring Gallium-68 PET-CT scanning to New Zealand, advocating for PRRT access through PHARMAC, and his decades of clinical leadership for NET patients.
NOTE: Work is underway to establish a fund to honour Malcolm and provide much-needed resources for the neuroendocrine cancer community in New Zealand.



